PET imaging with [18F]3′-deoxy-3′-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer

被引：0

作者：

Hinrich A. Wieder

Hans Geinitz

Robert Rosenberg

Florian Lordick

Karen Becker

Alexander Stahl

Ernst Rummeny

Jörg R. Siewert

Markus Schwaiger

Jens Stollfuss

机构：

[1] Technische Universität München,Department of Nuclear Medicine

[2] Technische Universität München,Department of Radiology

[3] Technische Universität München,Department of Radiotherapy

[4] Technische Universität München,Department of Surgery

[5] Technische Universität München,Department of Medicine III

[6] Technische Universität München,Department of Pathology

来源：

European Journal of Nuclear Medicine and Molecular Imaging | 2007年 / 34卷

关键词：

Rectal cancer; Therapy monitoring; FLT-PET; Proliferation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：878 / 883

页数：5

共 50 条

[11] 3′-Deoxy-3′-[18F]-Fluorothymidine PET Imaging Reflects PI3K-mTOR-Mediated Pro-Survival Response to Targeted Therapy in Colorectal Cancer
McKinley, Eliot T.
Zhao, Ping
Coffey, Robert J.
Washington, M. Kay
Manning, H. Charles
PLOS ONE, 2014, 9 (09):
[12] Semiautomatic synthesis of 3′-deoxy-3′-[18F]fluorothymidine using three precursors
Teng, B
Wang, SZ
Fu, Z
Dang, YH
Wu, ZH
Liu, LQ
APPLIED RADIATION AND ISOTOPES, 2006, 64 (02) : 187 - 193
[13] Positron Emission Tomography with [18F]-3'-Deoxy-3'fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: a Pilot Study
Dehdashti, Farrokh
Grigsby, Perry W.
Myerson, Robert J.
Nalbantoglu, ILKe
Ma, Changqing
Siegel, Barry A.
MOLECULAR IMAGING AND BIOLOGY, 2013, 15 (01) : 106 - 113
[14] Positron Emission Tomography with [18F]-3′-Deoxy-3′fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: a Pilot Study
Farrokh Dehdashti
Perry W. Grigsby
Robert J. Myerson
ILKe Nalbantoglu
Changqing Ma
Barry A. Siegel
Molecular Imaging and Biology, 2013, 15 : 106 - 113
[15] Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine (18F-FLT) PET/CT in Lung Cancer
Kairemo, Kalevi
Santos, Elmer B.
Macapinlac, Homer A.
Subbiah, Vivek
DIAGNOSTICS, 2020, 10 (01)
[16] Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3′-Deoxy-3′-[18F]Fluorothymidine in Preclinical Models of Lung Cancer
Schelhaas, Sonja
Held, Annelena
Wachsmuth, Lydia
Hermann, Sven
Honess, Davina J.
Heinzmann, Kathrin
Smith, Donna-Michelle
Griffiths, John R.
Faber, Cornelius
Jacobs, Andreas H.
CANCER RESEARCH, 2016, 76 (24) : 7096 - 7105
[17] Validity of Simplified 3′-Deoxy-3′-[18F]Fluorothymidine Uptake Measures for Monitoring Response to Chemotherapy in Locally Advanced Breast Cancer
Lubberink, Mark
Direcks, Wieteke
Emmering, Jasper
van Tinteren, Harm
Hoekstra, Otto S.
van der Hoeven, Jacobus J.
Molthoff, Carla F. M.
Lammertsma, Adriaan A.
MOLECULAR IMAGING AND BIOLOGY, 2012, 14 (06) : 777 - 782
[18] Preclinical Evidence That 3′-Deoxy-3′-[18F]Fluorothymidine PET Can Visualize Recovery of Hematopoiesis after Gemcitabine Chemotherapy
Schelhaas, Sonja
Held, Annelena
Baeumer, Nicole
Viel, Thomas
Hermann, Sven
Mueller-Tidow, Carsten
Jacobs, Andreas H.
CANCER RESEARCH, 2016, 76 (24) : 7089 - 7095
[19] Stability of 3′-Deoxy-3′-[18F]Fluorothymidine Standardized Uptake Values in Head and Neck Cancer Over Time
Ponto, Laura L. Boles
Menda, Yusuf
Dornfeld, Kenneth
Tewson, Timothy J.
Watkins, G. Leonard
Sunderland, John
Graham, Michael M.
Buatti, John
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2010, 25 (03) : 361 - 363
[20] A Pilot Study to Evaluate 3′-Deoxy-3′-18F-Fluorothymidine PET for Initial and Early Response Imaging in Mantle Cell Lymphoma
Herrmann, Ken
Buck, Andreas K.
Schuster, Tibor
Rudelius, Martina
Wester, Hans-Juergen
Graf, Nicolas
Scheuerer, Christine
Peschel, Christian
Schwaiger, Markus
Dechow, Tobias
Keller, Ulrich
JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (12) : 1898 - 1902

← 1 2 3 4 5 →